Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | BAP1 CL E G H | 8314 | 950 | OMIM:614327 | Tumor predisposition syndrome | . | | | 184 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | BRAF CL E G H | 673 | 1097 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 276 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | CASP8 CL E G H | 841 | 1509 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 37 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | CDKN2A CL E G H | 1029 | 1787 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 289 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 88 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | CYP2A6 CL E G H | 1548 | 2610 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 6 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | EGFR CL E G H | 1956 | 3236 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 257 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | ERBB2 CL E G H | 2064 | 3430 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 77 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 199 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | FASLG CL E G H | 356 | 11936 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 37 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | IRF1 CL E G H | 3659 | 6116 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 2 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | KRAS CL E G H | 3845 | 6407 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 196 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | MAP3K8 CL E G H | 1326 | 6860 | OMIM:211980 | Lung cancer, susceptibility to | . | | | | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | NDUFAF6 CL E G H | 137682 | 28625 | OMIM:618913 | FANCONI RENOTUBULAR SYNDROME 5; FRTS5 | | | | 39 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | PIK3CA CL E G H | 5290 | 8975 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 162 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | PPP2R1B CL E G H | 5519 | 9303 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 1 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 134 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | PRKN CL E G H | 5071 | 8607 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 138 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | SLC22A18 CL E G H | 5002 | 10964 | OMIM:211980 | Lung cancer, susceptibility to | . | | | 3 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 238 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | 911 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | TP53 CL E G H | 7157 | 11998 | OMIM:151623 | Li-Fraumeni syndrome | . | | | 911 | | |
HP:0030078 | HP:0030078 | Lung adenocarcinoma | 0 | ZNRF3 CL E G H | 84133 | 18126 | ORPHA:1501 | Adrenocortical carcinoma | HP:0040282 - Frequent | | | | | |